MedTrace Logo

Building an Outcomes Assessment Infrastructure to Assess Anxiety Treatment

NCT02305537 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 559

Last updated 2025-10-20

No results posted yet for this study

Summary

The collection of patient self-report and diagnostic data will allow us to examine the efficacy of the treatment delivered in the McLean Anxiety Mastery Program. Using data gathered through routine clinical care, the investigators seek to explore whether patients in treatment show improvements from admission to discharge, compared to patients on the waitlist, and whether these gains are maintained three months post-discharge. The following are included as examples of some of the study's hypotheses.

Conditions

  • Social Anxiety Disorder
  • Specific Phobia
  • Separation Anxiety Disorder
  • Panic Disorder
  • Agoraphobia
  • Obsessive-Compulsive Disorder

Interventions

BEHAVIORAL

McLean Anxiety Mastery Program

Cognitive-Behavioral Therapy with Exposure and Response Prevention

Sponsors & Collaborators

  • Mclean Hospital

    lead OTHER

Principal Investigators

  • Jacqueline Sperling, Ph.D. · Mclean Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2024-11-30
Completion
2024-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02305537 on ClinicalTrials.gov